What problems have been reported in newborns exposed to lorazepam during late pregnancy or delivery?

Newborns exposed to lorazepam in late pregnancy or at delivery have reportedly experienced hypoactivity, hypotonia, hypothermia, respiratory depression, apnoea, feeding problems and impaired metabolic response to cold stress, with physical dependence and postnatal withdrawal possible after prolonged maternal use.